Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19.0Revenue (TTM) $M0.8Net Margin (%)-3,236.3Altman Z-Score-44.7
Enterprise Value $M17.9EPS (TTM) $-176.4Operating Margin %-3,301.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)-3,236.3Higher ROA y-yN
Price/Book6.910-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %-29.4Current Ratio1.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-191.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,668.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M2.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ETRM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ETRMBill Gates 2009-06-30 Sold Out $117 - $25577.3
($14138.5)
$ 7.96-100%Sold Out0
ETRMBill Gates 2009-03-31 Buy $103.49 - $15686.6
($6841.19)
$ 7.96-100%New holding
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ETRM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ETRM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DeLange Peter M.SVP, Ops & Bus Dev 2016-06-03Buy286$38.5-79.32view
GLADNEY DAN WCEO 2015-11-12Buy714$189-95.79view
KNUDSON MARK BChrmn, Pres & CEO 2015-11-12Buy295$168-95.26view
KNUDSON MARK BChrmn, Pres & CEO 2015-08-13Buy289$262.49-96.97view
GLADNEY DAN WCEO 2015-05-16Buy81$755.98-98.95view
FRIEDMAN CATHYDirector 2014-06-19Buy11$1784.95-99.55view
EVNIN LUKEDirector 2014-01-08Sell530$2624.93-99.7view
EVNIN LUKEDirector 2014-01-08Sell530$2624.93-99.7view
Jansz Anthony P.Director 2013-02-27Buy143$997.47-99.2view
WHITEBOX ADVISORS LLC 2012-06-27Sell45$3380.91-99.76view

Quarterly/Annual Reports about ETRM:

News about ETRM:

Articles On GuruFocus.com
Kevin Douglas Bets on EnteroMedics; Popeyes and AMERCO Top Estimates May 28 2015 
Canaccord Genuity Remains Bullish on EnteroMedics Following Q4 Earnings Feb 19 2015 
Analysts Are Bullish On EnteroMedics Following FDA Approval Of Obesity Treatment Jan 16 2015 
EnteroMedics Inc. Reports Operating Results (10-K) Mar 07 2011 
EnteroMedics Inc. Reports Operating Results (10-Q) Nov 08 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) Aug 06 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) May 07 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) Nov 16 2009 
EnteroMedics Inc. Reports Operating Results (10-Q) Aug 07 2009 
EnteroMedics Inc. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
Biotech Movers: Illumina, Inc. (ILMN) And EnteroMedics Inc (ETRM) Jan 12 2017
Stock Market Roundup, Jan. 10: NVDA Self-Driving Cars, ETRM Soars Jan 10 2017
Still Struggling to Put Money to Work Jan 10 2017
EnteroMedics and GenVec Post Substantial Gains as the NASDAQ is Pushed to Record High Jan 10 2017
Biotech Movers: EnteroMedics Inc (ETRM) And Stemline Therapeutics Inc (STML) Jan 09 2017
Bullish and Bearish Reversals in the Market Jan 09 2017
ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 05 2017
Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday Jan 05 2017
EnteroMedics Announces vBloc® Neurometabolic Therapy Now Available at MedStar Health and Roper St.... Jan 05 2017
EnteroMedics Announces vBloc® Neurometabolic Therapy Now Available at MedStar Health and Roper St.... Jan 05 2017
EnteroMedics Announces Retirement of All Senior Convertible Notes Dec 29 2016
EnteroMedics Announces Retirement of All Senior Convertible Notes Dec 29 2016
ENTEROMEDICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Dec 28 2016
Blog Coverage EnteroMedics Announced 1-for-70 Reverse Stock Split and Amortization of its... Dec 27 2016
EnteroMedics Announces 1-for-70 Reverse Stock Split Dec 23 2016
ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 23 2016
EnteroMedics Announces 1-for-70 Reverse Stock Split Dec 23 2016
ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 20 2016
Commercial Patient Data Confirms Success of EnteroMedics' vBloc® Therapy in Combination with... Dec 15 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)